Cover Image

Ferroptosis in cardiovascular disease: regulatory mechanisms and therapeutic implications

Ferroptosis, an iron-dependent form of regulated cell death, has been identified as a key factor in the pathogenesis and progression of various cardiovascular diseases (CVDs). The molecular basis of ferroptosis involves lipid peroxidation, iron dysregulation, and antioxidant pathways. Accumulating e...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhao, Yiheng (Author) , Linkermann, Andreas Günter (Author) , Takahashi, Masafumi (Author) , Li, Qingguo (Author) , Zhou, Xiang (Author)
Format: Article (Journal)
Language:English
Published: 1 September 2025
In: European heart journal
Year: 2025, Volume: 46, Issue: 33, Pages: 3247-3260
ISSN:1522-9645
DOI:10.1093/eurheartj/ehaf374
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/eurheartj/ehaf374
Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/eurheartj/article/46/33/3247/8156680
Get full text
Author Notes:Yiheng Zhao, Andreas Linkermann, Masafumi Takahashi, Qingguo Li and Xiang Zhou
Description
Summary:Ferroptosis, an iron-dependent form of regulated cell death, has been identified as a key factor in the pathogenesis and progression of various cardiovascular diseases (CVDs). The molecular basis of ferroptosis involves lipid peroxidation, iron dysregulation, and antioxidant pathways. Accumulating evidence suggests that ferroptosis is associated with various CVDs, including atherosclerosis, myocardial ischaemia-reperfusion injury, cardiac hypertrophy, and diverse cardiomyopathies. In addition to ferroptosis inhibitors, several novel ferroptosis-targeting therapies have emerged, including new uses for existing drugs, plant-derived compounds, and targeted drug delivery. This review synthesizes current knowledge, identifies research gaps to summarize the complex regulatory mechanisms of ferroptosis, and provides an overview of its functions in CVDs. The innovative therapeutic strategies targeting ferroptosis may lead to a paradigm change in the treatment of CVDs.
Item Description:Online veröffentlicht: 4. Juni 2025
Gesehen am 20.10.2025
Physical Description:Online Resource
ISSN:1522-9645
DOI:10.1093/eurheartj/ehaf374

Similar Items